Integrated pharmacokinetic-pharmacodynamic modeling and metabolomic research on polyphenol-rich fraction of Thymus quinquecostatus Celak. Alleviating cerebral ischemia-reperfusion injury

J Ethnopharmacol. 2024 Aug 10:330:118229. doi: 10.1016/j.jep.2024.118229. Epub 2024 Apr 25.

Abstract

Ethnopharmacological relevance: Thymus quinquecostatus Celak., a member of thymus genus in Lamiaceae family, has been used as a folk medicine for relieving exterior syndrome and alleviating pain in China. The polyphenol-rich fraction (PRF) derived from Thymus quinquecostatus Celak. had been validated that it can protect cerebral ischemia-reperfusion injury (CIRI) by activating Keap1/Nrf2/HO-1 signaling pathway.

Aim of this study: To explore effective components and their pharmacokinetic and pharmacodynamic characteristics as well as possible mechanisms of PRF in treating CIRI.

Materials and methods: Normal treated group (NTG) and tMCAO model treated group (MTG) rats were administrated PRF intragastrically. The prototype components and metabolites of PRF in plasma and brain were analyzed by the UPLC-Q-Exactive Orbitrap MSn method. Subsequently, the pharmacokinetics properties of indicative components were performed based on HPLC-QQQ-MS/MS. SOD and LDH activities were determined to study the pharmacodynamic (PD) properties of PRF. The PK-PD relationship of PRF was constructed. In addition, the effect of PRF on endogenous metabolites in plasma and brain was investigated using metabolomic method.

Results: Salvianic acid A, caffeic acid, rosmarinic acid, scutellarin, and apigenin-7-O-glucuronide were selected as indicative components based on metabolic analysis. The non-compartmental parameters were calculated for indicative components in plasma and brain of NTG and MTG rats. Furthermore, single-component and multi-component PK-PD modeling involved Emax, Imax PD models for effect indexes were fitted as well as ANN models were established, which indicated that these components can work together to regulate SOD and LDH activities in plasma and SOD activity in brain tissue to improve CIRI. Additionally, PRF may ameliorate CIRI by regulating the disorder of endogenous metabolites in lipid metabolism, amino acid metabolism, and purine metabolism pathways in vivo, among which lipid metabolism and purine metabolism are closely related to oxidative stress.

Conclusion: The PK-PD properties of effect substances and mechanisms of PRF anti-CIRI were further elaborated. The findings provide a convincing foundation for the application of T. quinquecostatus Celak. in the maintenance of human health disorders.

Keywords: Cerebral ischemia-reperfusion injury; Metabolomics; Pharmacokinetic-pharmacodynamic; Polyphenol-rich fraction; Thymus quinquecostatus Celak.

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain Ischemia / drug therapy
  • Disease Models, Animal
  • Drugs, Chinese Herbal / pharmacokinetics
  • Drugs, Chinese Herbal / pharmacology
  • Infarction, Middle Cerebral Artery / drug therapy
  • Male
  • Metabolomics*
  • Neuroprotective Agents / pharmacokinetics
  • Neuroprotective Agents / pharmacology
  • Plant Extracts / pharmacokinetics
  • Plant Extracts / pharmacology
  • Polyphenols* / pharmacokinetics
  • Polyphenols* / pharmacology
  • Rats
  • Rats, Sprague-Dawley*
  • Reperfusion Injury* / drug therapy
  • Reperfusion Injury* / metabolism
  • Thymus Plant* / chemistry

Substances

  • Polyphenols
  • Plant Extracts
  • Neuroprotective Agents
  • Drugs, Chinese Herbal